JNCI Journal of the National Cancer Institute
Other literature type . 2013
Data sources: Europe PubMed Central
Overcoming Resistance to MAPK Pathway Inhibitors
Authors: Michael A, Davies; Scott, Kopetz;
doi: 10.1093/jnci/djs507
pmid: 23250957
Overcoming Resistance to MAPK Pathway Inhibitors
Related Organizations
- The University of Texas MD Anderson Cancer Center United States
Keywords
Ubiquitin-Protein Ligases, Benzamides, Animals, Humans, Antineoplastic Agents, Benzimidazoles, Molecular Targeted Therapy, Mitogen-Activated Protein Kinases, Melanoma
Ubiquitin-Protein Ligases, Benzamides, Animals, Humans, Antineoplastic Agents, Benzimidazoles, Molecular Targeted Therapy, Mitogen-Activated Protein Kinases, Melanoma
1 Research products, page 1 of 1
- 2012IsAmongTopNSimilarDocuments
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).15 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
citations
Citations provided by BIP!
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
popularity
Popularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
15
Average
Average
Average
bronze
Beta
Related to Research communities
